The newly titled Nurse Practitioner Perspective rolls out this month, keeping pace with an educational shift in the nursing field.
The Washington Post was publishing studies and press releases in its science section until criticism prompted it to stop.
A month after UBM Canon closed the B2B magazine, marketing firm Outcomes LLC announced its return to twice-a-year publication.
The move to digitize a series of books it co-created with Disney for kids with type 1 diabetes was spurred by a meeting with the online diabetes community.
The Heath, Labor and Welfare ministry says a publisher passed off advertorials as articles.
The retraction comes six months after researchers were fired over misrepresented data.
Summaries max out at 160 characters and most queries are clinical.
PNAS fixed a citation issue by adding quotes, but readers are not completely sold.
The publisher says the latest release enriches the CE experience through direct links to Nursing Advisor content.
Remedy Health is hoping a new design for its flagship portal can give it an edge over rivals WebMD and Everyday Health.
American Medical News' 55-year publishing run will come to a close this year, the AMA, its publisher, said today.
Reuters Health's former executive editor has plans for cultivating a broader, richer experience for MedPage Today readers. He's already got a list of writers he's looking to recruit.
Publisher middleman DeepDyve has launched a five-minute "freemium" service that CEO William Park says saves researchers money, and prevents the hassle of buying off-target research. Publishers such as Wiley support the service through cross-promotions on their websites.
Responsive-design PracticeUpdate absorbs OncologyStat to become a more wide-ranging resource of curated content that spans the medical field, not just the Dutch publisher's media.
Allergan's 2013 outlook scores points with at least one analyst, Amgen is laying off 160 staff, and Wiley renews a publishing relationship.
An expert witness in a 2008 lawsuit highlights holes in clinical data, and finds that corporate and published trial data do not necessarily correspond.
Elsevier launches a new title, FDA is holding a public hearing on opioids and chronic pain.
Healthcare PR giant Dan Edelman dies; Pfizer says 'no comment' on breakup speculation; Publicis Healthcare snags a new SVP; Lippincott gives nurses a new drug diagnosis tool.